Development of novel entry inhibitors targeting emerging viruses.
about
Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.Protease inhibitors targeting coronavirus and filovirus entryBroad-spectrum antivirals against viral fusion.The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.A Simple Platform for the Rapid Development of Antimicrobials.
P2860
Development of novel entry inhibitors targeting emerging viruses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Development of novel entry inhibitors targeting emerging viruses.
@ast
Development of novel entry inhibitors targeting emerging viruses.
@en
type
label
Development of novel entry inhibitors targeting emerging viruses.
@ast
Development of novel entry inhibitors targeting emerging viruses.
@en
prefLabel
Development of novel entry inhibitors targeting emerging viruses.
@ast
Development of novel entry inhibitors targeting emerging viruses.
@en
P2860
P356
P1476
Development of novel entry inhibitors targeting emerging viruses.
@en
P2093
Yanchen Zhou
P2860
P304
P356
10.1586/ERI.12.104
P577
2012-10-01T00:00:00Z